- Home
- CMMB vs MDJH Comparison
CMMB vs MDJH Comparison
Compare CMMB & MDJH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMMB
- MDJH
- Stock Information
- Founded
- CMMB 2004
- MDJH 2002
- Country
- CMMB Israel
- MDJH United Kingdom
- Employees
- CMMB N/A
- MDJH N/A
- Industry
- CMMB Biotechnology: Pharmaceutical Preparations
- MDJH Real Estate
- Sector
- CMMB Health Care
- MDJH Finance
- Exchange
- CMMB Nasdaq
- MDJH Nasdaq
- Market Cap
- CMMB 20.9M
- MDJH 13.6M
- IPO Year
- CMMB N/A
- MDJH 2019
- Fundamental
- Price
- CMMB $1.31
- MDJH $0.53
- Analyst Decision
- CMMB Strong Buy
- MDJH
- Analyst Count
- CMMB 3
- MDJH 0
- Target Price
- CMMB $5.67
- MDJH N/A
- AVG Volume (30 Days)
- CMMB 158.7K
- MDJH 47.9K
- Earning Date
- CMMB 11-07-2024
- MDJH 01-01-0001
- Dividend Yield
- CMMB N/A
- MDJH N/A
- EPS Growth
- CMMB N/A
- MDJH N/A
- EPS
- CMMB N/A
- MDJH N/A
- Revenue
- CMMB N/A
- MDJH $114,849.00
- Revenue This Year
- CMMB N/A
- MDJH N/A
- Revenue Next Year
- CMMB N/A
- MDJH N/A
- P/E Ratio
- CMMB N/A
- MDJH N/A
- Revenue Growth
- CMMB N/A
- MDJH 289.97
- 52 Week Low
- CMMB $0.42
- MDJH $0.53
- 52 Week High
- CMMB $2.55
- MDJH $2.10
- Technical
- Relative Strength Index (RSI)
- CMMB 40.90
- MDJH 26.05
- Support Level
- CMMB $1.09
- MDJH $0.62
- Resistance Level
- CMMB $1.59
- MDJH $0.68
- Average True Range (ATR)
- CMMB 0.17
- MDJH 0.05
- MACD
- CMMB -0.04
- MDJH 0.00
- Stochastic Oscillator
- CMMB 31.88
- MDJH 0.10
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.
About MDJH MDJM LTD
MDJM Ltd is a real estate service company. The company provides real estate agency services to real estate developer clients, as well as real estate consulting services and independent training services on an as-needed basis. It offers consulting, marketing planning, advertising services, and sales strategies to real estate clients. The company income is derived from commission-based services and minimal consulting and other services. The company has two operating segments; the real estate agent services segment and the hospitality business segment. It derives a majority of its revenue from the People's Republic of China.